30 Sep Rocket Pharmaceuticals
Posted at 00:13h
in
Kinnari Patel, President, Head of R&D and Chief Operating Officer
Oct. 7 | 1:45pm | FLW Ballroom F
(NASDAQ: RCKT)
Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of investigational genetic therapies designed to correct the root cause of complex and rare disorders. Rocket’s multi-platform approach and pipeline of LV hematology and AAV cardiovascular programs allows us to design the optimal gene therapy for each indication, creating potentially transformative options that enable people living with devastating rare diseases to experience long and full lives.
